KBC Group NV »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by KBC Group NV

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-03-31 $283k 300k 0.94
2023-09-30 $279k 300k 0.93

More positions owned by KBC Group NV

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Pepsi (PEP)
Qualcomm (QCOM)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
Accenture Plc Ireland Shs Class A (ACN)
UnitedHealth (UNH)
Merck & Co (MRK)
Adobe Systems Incorporated (ADBE)

View all positions for KBC Group NV

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Calamos Advisors
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1